Integrated Pulmonary Index in Gastroscopic Procedures

Gaziosmanpasa Research and Education Hospital

Status: Enrolling

Conditions: Endoscopy

Treatments: Procedure: gastroscopy

Study type: Observational

Funder types: Other

Identifiers

NCT05829486

147/22

Details and patient eligibility

About

Various complications are the leading cause of morbidity in sedation practices in endoscopic procedures, and guidelines recommend continuous monitoring of circulation, respiratory function, and ventilation. Integrated Pulmonary Index (IPI), one of the methods that can be used in this monitoring, gives a single numerical value obtained by continuous and simultaneous joint mathematical analysis of Oxygen saturation, End-tidal carbon dioxide concentration, respiratory rate, and heart rate values and is a good monitorization in these interventions. and provides tracking. In this study, the aim is to determine the role of IPI in the diagnosis and follow-up of respiratory complications in patients who were sedated during gastroscopy procedures.

Full description

IPI EtCO2 is a monitoring method consisting of respiratory rate, SPO2 and heart rate parameters. While EtCO2 is measured with nasal capnography, SPO2, heart rate, respiratory rate are measured with finger probe and it will show instant measurement of respiratory status. IPI takes values between 1-10. An IPI value of 8 and above will indicate normal values, a value between 5-7 will indicate that the respiratory status of the patient should be carefully examined and intervened if necessary, values of 4 and below will definitely indicate that the patient's respiratory status should be intervened.

Blood pressure measurement will be made with a sphingmomanometer noninvasively at certain time intervals with the help of a cuff that will be placed on the patient's arm area.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA 1-2-3 risk scored patients,
• patients over the age of 18 who will undergo endoscopic intervention

Exclusion criteria

• Patients who need mechanical ventilator support,
• patients who need emergency endoscopic intervention,
• patients with a history of substance abuse,
• patients with a history of allergy to the drugs to be used,
• pregnant women will be excluded from the study.

Trial design

60 participants in 2 patient groups

ketaprop

Description:

At the beginning of anesthesia, 0.25 mg/kg ketamine and 0.75 mg/kg propofol will be administered.

Treatment:

Procedure: gastroscopy

remiprop

Description:

At the beginning of anesthesia, 1 mcg/kg of remifentanil and 0.75 mg/kg propofol will be administered.

Treatment:

Procedure: gastroscopy